نتائج البحث

Efficacy and safety of extended adjuvant temozolomide compared to standard adjuvant temozolomide in glioblastoma: Updated systematic review and meta-analysis.

• Authors : Gupta T; Department of Radiation Oncology, ACTREC/TMH, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.; Talukdar R

• Source: Neuro-oncology practice [Neurooncol Pract] 2022 May 07; Vol. 9 (5), pp. 354-363. Date of Electronic Publication: 2022 May 07 (Print Publication: 2022).Publisher: Oxford University Press Country of Publication: England NLM ID: 101640528 Publication Model: eCollection Cited Medium: Print ISSN:

تفاصيل العنوان

Optimal duration of adjuvant temozolomide in glioblastoma: An unsolved and unsolvable problem.

• Authors : Balana C; Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), Institut Catala d'Oncologia (ICO) Badalona, Badalona, Spain.

• Source: Neuro-oncology practice [Neurooncol Pract] 2022 Jun 22; Vol. 9 (5), pp. 349-350. Date of Electronic Publication: 2022 Jun 22 (Print Publication: 2022).Publisher: Oxford University Press Country of Publication: England NLM ID: 101640528 Publication Model: eCollection Cited Medium: Print ISSN:

تفاصيل العنوان

Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study).

• Authors : Ahn GS; Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.; Hwang K

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/radiotherapy ; Glioma*/Glioma*/Glioma*/drug therapy

• Source: Cancer research and treatment [Cancer Res Treat] 2022 Apr; Vol. 54 (2), pp. 396-405. Date of Electronic Publication: 2021 Jul 06.Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

A Simple Preoperative Blood Count to Stratify Prognosis in Isocitrate Dehydrogenase-Wildtype Glioblastoma Patients Treated with Radiotherapy plus Concomitant and Adjuvant Temozolomide.

• Authors : Clavreul A; Université d'Angers, CHU d'Angers, CRCINA, F-49000 Angers, France.; Département de Neurochirurgie, CHU Angers, F-49933 Angers, France.

• Source: Cancers [Cancers (Basel)] 2021 Nov 18; Vol. 13 (22). Date of Electronic Publication: 2021 Nov 18.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print)

تفاصيل العنوان

Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival.

• Authors : Huang B; Department of Neurosurgery, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Gulou District, Fuzhou City, Fujian Province, China.; Yu Z

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy; Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/therapeutic use

• Source: BMC neurology [BMC Neurol] 2021 Nov 02; Vol. 21 (1), pp. 424. Date of Electronic Publication: 2021 Nov 02.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377

تفاصيل العنوان

Outcomes in Elderly Patients with Glioblastoma Multiforme Treated with Short-Course Radiation Alone Compared to Short-Course Radiation and Concurrent and Adjuvant Temozolomide Based on Performance Status and Extent of Resection.

• Authors : Mir T; Juravinski Cancer Center, Department of Oncology, Radiation Oncology, McMaster University, 699 Concession St., Hamilton, ON L8V5C2, Canada.; Pond G

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy; Aged

• Source: Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Jun 26; Vol. 28 (4), pp. 2399-2408. Date of Electronic Publication: 2021 Jun 26.Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729

تفاصيل العنوان

Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide.

• Authors : Topkan E; Başkent University Medical Faculty, Department of Radiation Oncology, Adana, Turkey.; Besen AA

Subjects: Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*metabolism ; Glioblastoma/Glioblastoma/Glioblastoma/*metabolism ; Inflammation/Inflammation/Inflammation/*metabolism

• Source: Mediators of inflammation [Mediators Inflamm] 2020 May 23; Vol. 2020, pp. 4392189. Date of Electronic Publication: 2020 May 23 (Print Publication: 2020).Publisher: Wiley Country of Publication: United States NLM ID: 9209001 Publication Model: eCollection Cited Medium: Internet ISSN: 1466-1861

تفاصيل العنوان

Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study).

• Authors : Hwang K; Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.; Kim TM

Subjects: Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/Antineoplastic Agents, Alkylating/*therapeutic use ; Glioma/Glioma/Glioma/*drug therapy ; Temozolomide/Temozolomide/Temozolomide/*therapeutic use

• Source: Cancer research and treatment [Cancer Res Treat] 2020 Apr; Vol. 52 (2), pp. 505-515. Date of Electronic Publication: 2019 Oct 28.Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma.

• Authors : Massey SC; Mathematical NeuroOncology Laboratory, Precision Neurotherapeutics Innovation Program, Mayo Clinic, Phoenix, Arizona, United States of America.; White H

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/diagnostic imaging ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/metabolism

• Source: PloS one [PLoS One] 2020 Mar 27; Vol. 15 (3), pp. e0230492. Date of Electronic Publication: 2020 Mar 27 (Print Publication: 2020).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma multiforme: a meta-analysis and systematic review.

• Authors : Alimohammadi E; Neurosurgery Department.; Bagheri SR

• Source: Oncology reviews [Oncol Rev] 2020 Feb 18; Vol. 14 (1), pp. 461. Date of Electronic Publication: 2020 Feb 18 (Print Publication: 2020).Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 101519906 Publication Model: eCollection Cited Medium: Print ISSN:

تفاصيل العنوان